News
-
-
PRESS RELEASE
Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants
Jaguar Health, Inc. strengthens balance sheet by restructuring debt and royalty obligations. Sharp focus on global development program for crofelemer. CEO Lisa Conte prioritizes capitalization -
-
-
-
-
-
-
-
PRESS RELEASE
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for Jaguar Health Inc. Analyst Christian Orquera lowers target price to USD 7.50 due to licensing agreement with Future Pak and focus on core drug development